Skip to main content

Advertisement

SpringerLink
Log in

Ocular involvement in patients with primary CNS lymphoma

  • Clinical Study - Patient Studies
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To describe the demographics, clinical characteristics, and treatment outcomes in patients with primary CNS lymphoma (PCNSL) with ocular involvement. A retrospective chart review was conducted on 61 patients who were diagnosed with PCNSL from January 2000 to October 2008 at the Asan Medical Center, Seoul, Korea. Among 46 patients who underwent ophthalmologic examination, 13 (28%) showed intraocular involvement. Mean age at diagnosis was 52.8 years, and 54% of patients were female. Diagnosis of PCNSL was made by vitrectomy (1 patient) or brain biopsy and/or CSF cytology (12 patients). In 4 (31%) patients, ocular symptoms preceded CNS symptoms. The most common ocular symptom was decreased visual acuity. Nine patients showed bilateral involvement. Intraocular findings included retinal infiltrative lesions (3 eyes), vitritis/vitreous opacity (5 eyes), or both (14 eyes). In addition to systemic chemotherapy and/or radiotherapy, vitrectomy and/or intravitreal methotrexate was utilized in 8 patients. Mean survival duration was 32.2 months (range 2–120 months). Although rare, the number of patients with PCNSL seems to be increasing in Korea. Early detection and dedicated treatment of intraocular lymphoma may result in improved visual outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Smith JR, Rosenbaum JT, Wilson DJ et al (2002) Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109:1709–1716

    Article  PubMed  Google Scholar 

  2. Schabet M (1999) Epidemiology of primary CNS lymphoma. J Neurooncol 43:199–201

    Article  CAS  PubMed  Google Scholar 

  3. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859–863

    CAS  PubMed  Google Scholar 

  4. Lee SH, Kim DJ, Kim IT (2005) A case of primary central nervous system lymphoma with ocular involvement. J Korean Ophthalmol Soc 46:565–571

    CAS  Google Scholar 

  5. Schlegel U, Schmidt-Wolf IG, Deckert M (2000) Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 181:1–12

    Article  CAS  PubMed  Google Scholar 

  6. Coté TR, Manns A, Hardy CR, Yellin FJ, Hartge P (1996) Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDs/Cancer Study Group. J Natl Cancer Inst 88:675–679

    Article  PubMed  Google Scholar 

  7. Nasir S, DeAngelis LM (2000) Update on the management of primary CNS lymphoma. Oncology (Williston Park) 14:228–234, Discussion 237–242, 244

    CAS  Google Scholar 

  8. Suh YL, Koo H, Kim TS et al (2002) Tumors of the central nervous system in Korea: a multicenter study of 3221 cases. J Neurooncol 56:251–259

    Article  PubMed  Google Scholar 

  9. Ko YH, Kim CW, Park CS et al (1998) REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular study group of the Korean society of pathologists. Revised European-American lymphoma. Cancer 83:806–812

    Article  CAS  PubMed  Google Scholar 

  10. Chan CC, Wallace DJ (2004) Intraocular lymphoma: update on diagnosis and management. Cancer Control 11:285–295

    PubMed  Google Scholar 

  11. Gill MK, Jampol LM (2001) Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol 45:463–471

    Article  CAS  PubMed  Google Scholar 

  12. Salih SB, Saeed AB, Alzahrani M, Al Qahtani M, Haider A, Palker V (2009) Primary CNS lymphoma presenting as fever of unknown origin. J Neurooncol 93:401–404

    Article  PubMed  Google Scholar 

  13. Batchelor T, Loefflers JS (2006) Primary CNS lymphoma. J Clin Oncol 24:1281–1288

    Article  CAS  PubMed  Google Scholar 

  14. Braus DF, Schwechheimer K, Müller-Hermelink HK, Schwarzkopf G, Volk B, Mundinger F (1992) Primary cerebral malignant non-Hodgkin’s lymphomas: a retrospective clinical study. J Neurol 239:117–124

    Article  CAS  PubMed  Google Scholar 

  15. Herrlinger U, Schabet M, Clemens M et al (1998) Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand 97:257–264

    Article  CAS  PubMed  Google Scholar 

  16. Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis RL (1974) Primary malignant lymphomas of the central nervous system. Cancer 34:1293–1302

    Article  CAS  PubMed  Google Scholar 

  17. Grote TH, Grosh WW, List AF, Wiley R, Cousar JB, Johnson DH (1989) Primary lymphoma of the central nervous system. A report of 20 cases and a review of the literature. Am J Clin Oncol 12:93–100

    Article  CAS  PubMed  Google Scholar 

  18. Jack CR Jr, Reese DF, Scheithauer BW (1986) Radiographic findings in 32 cases of primary CNS lymphoma. AJR Am J Roentgenol 146:271–276

    PubMed  Google Scholar 

  19. Sierra del Rio M, Rousseau A, Soussainc C, Ricard D, Hoang-Xuan K (2009) Primary CNS lymphoma in immunocompetent patients. Oncologist 14:526–539

    Article  CAS  PubMed  Google Scholar 

  20. Grimm SA, McCannel CA, Omuro AM et al (2008) Primary CNS lymphoma with intraocular involvement: international PCNSL collaborative group report. Neurology 71:1355–1360

    Article  CAS  PubMed  Google Scholar 

  21. Vicuna-Kojchen J, Frenkel S, Siegal T, Shalom E, Chowers I, Pe’er J (2008) Maculopathy in patients with primary CNS lymphoma treated with chemotherapy in conjunction with blood brain barrier disruption. Br J Ophthalmol 92:231–235

    Article  CAS  PubMed  Google Scholar 

  22. Suh MH, Yu HG (2009) Clinical manifestations of intraocular lymphoma. J Korean Ophthalmol Soc 50:78–84

    Article  Google Scholar 

  23. Char DH, Ljung BM, Deschênes J, Miller TR (1988) Intraocular lymphoma: immunological and cytological analysis. Br J Ophthalmol 72:905–911

    Article  CAS  PubMed  Google Scholar 

  24. Karma A, von Willebrand EO, Tommila PV, Paetau AE, Oskala PS, Immonen IJ (2007) Primary intraocular lymphoma: improving the diagnostic procedure. Ophthalmology 114:1372–1377

    Article  PubMed  Google Scholar 

  25. Coupland SE, Bechrakis NE, Anastassiou G et al (2003) Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with masquerade syndrome. Graefes Arch Clin Exp Ophthalmol 241:860–870

    Article  PubMed  Google Scholar 

  26. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR (1987) Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 94:1631–1639

    CAS  PubMed  Google Scholar 

  27. Wallace DJ, Shen D, Reed GF et al (2006) Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma. Invest Ophthalmol Vis Sci 47:2750–2756

    Article  PubMed  Google Scholar 

  28. Ferreri AJ, Blay JY, Reni M et al (2002) Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ann Oncol 13:531–538

    Article  CAS  PubMed  Google Scholar 

  29. Basso U, Brandes AA (2002) Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma. Eur J Cancer 38:1298–1312

    Article  CAS  PubMed  Google Scholar 

  30. Henson JW, Yang J, Batchelor T (1999) Intraocular methotrexate level after high-dose intravenous infusion. J Clin Oncol 17:1329

    CAS  PubMed  Google Scholar 

  31. Isobe K, Ejima Y, Tokumaru S et al (2006) Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan. Leuk Lymphoma 47:1800–1805

    Article  PubMed  Google Scholar 

  32. Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JW (2003) High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9:711–715

    CAS  PubMed  Google Scholar 

  33. Frenkel S, Hendler K, Siegal T, Shalom E, Pe’er J (2008) Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthal 92:383–388

    Article  CAS  Google Scholar 

  34. Freilich RJ, DeAngelis LM (1995) Primary central nervous system lymphoma. Neurol Clin 13:901–914

    CAS  PubMed  Google Scholar 

  35. DeAngelis LM, Yahalom J, Thaler HT, Kher U (1992) Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635–643

    CAS  PubMed  Google Scholar 

  36. Abrey LE, Ben-Porat L, Panageas KS et al (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24:5711–5715

    Article  PubMed  Google Scholar 

  37. Ferreri AJ, Blay JY, Reni M et al (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 15:266–272

    Article  Google Scholar 

  38. Bernstein M, Parrent AG (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81:165–168

    Article  CAS  PubMed  Google Scholar 

  39. Kulkarni AV, Guha A, Lozano A, Bernstein M (1998) Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 89:31–35

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (#A080557).

Author information

Authors and Affiliations

  1. Department of Ophthalmology, College of Medicine, University of Ulsan, Asan Medical Center, 388-1 Pungnap-2-dong, Songpa-gu, Seoul, 138-736, Korea

    Jung Taeck Hong, Ju Byung Chae, Joo Yong Lee, June-Gone Kim & Young Hee Yoon

Authors
  1. Jung Taeck Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ju Byung Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joo Yong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. June-Gone Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Young Hee Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Young Hee Yoon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hong, J.T., Chae, J.B., Lee, J.Y. et al. Ocular involvement in patients with primary CNS lymphoma. J Neurooncol 102, 139–145 (2011). https://doi.org/10.1007/s11060-010-0303-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0303-9

Keywords

Search

Navigation